Professional Documents
Culture Documents
Name Received Collected Dummy N146: Interpretation
Name Received Collected Dummy N146: Interpretation
Lab No. 153672637 Age: 33 Years Gender: Male Reported 31/7/2020 3:35:33PM
RESULTS
SPINOCEREBELLAR PP2R2B gene CAG Repeats PP2R2B gene CAG Repeats Allele
ATAXIA TYPE 12 Allele 1 2
NOT DETECTED 30 30
Interpretation
--------------------------------------------------------------------------
| RESULT | REMARKS (As per reference Bahl et al., 2005) |
|--------------------|-----------------------------------------------------|
| Detected | Indicates >51 CAG repeats in the sample submitted |
|--------------------|-----------------------------------------------------|
| Grey Zone | Indicates 32-51 CAG repeats in the sample submitted |
| -------------------|-----------------------------------------------------|
| Not Detected | Indicates <32 CAG repeats in the sample submitted |
|--------------------|-----------------------------------------------------|
| Indeterminate | Indicates presence of inherent inhibitors in the |
| | sample submitted |
--------------------------------------------------------------------------
Note
1. Results must be interpreted in context with clinical findings, family history and other relevant laboratory
data
2. This is an in-house developed assay
3. Test conducted on EDTA whole blood
4. Genetic Counselling and clinical correlation is recommended.
Comment
Spinocerebellar ataxia type 12 (SCA12) is an autosomal dominant cerebellar ataxia (ADCA) characterized by
progressive degeneration of cerebellum, brain stem and spinal cord. SCA12 is caused by an expansion in a
CAG repeat in the PPP2R2B gene located on chromosome 5q32. Age of onset ranges from 8-55 years. Most
individuals present in the fourth decade with upper extremity tremor, progressing over several decades to
include head tremor, gait ataxia, dysmetria, dysdiadokinesis, hyperreflexia, axial dystonia, facial myokymia,
paucity of movement, abnormal eye movements, and in the older subjects, dementia. Symptoms may include
subclinical sensory or sensorimotor neuropathy. MRI and CT scan report may show cortical and cerebellar
atrophy. In the presence of clinical findings consistent with SCA12, an expansion of 51 or more CAG triplets
within PPP2R2B is diagnostic.
References
Bahl, S., Virdi, K., Mittal, U., Sachdeva, M. P., Kalla, A. K., Holmes, S. E., O'Hearn, E., Margolis, R. L., Jain,
PatientReportSCSuperPanel.FLOWCYTO_DYNAMIC_SC (Version: 6)
*153672637*
Page 1 of 2
.
Lab No. 153672637 Age: 33 Years Gender: Male Reported 31/7/2020 3:35:33PM
S., Srivastava, A. K., Mukerji, M. Evidence of a common founder for SCA12 in the Indian population. Ann.
Hum. Genet. 69: 528-534, 2005. [PubMed: 16138911]
*Test results released pertain to the specimen submitted .*All test results are dependent on the quality of the sample received by the Laboratory .
*Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .*Sample
repeats are accepted on request of Referring Physician within 7 days post reporting.*Report delivery may be delayed due to unforeseen
circumstances. Inconvenience is regretted.*Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit
request within 72 hours post reporting.*Test results may show interlaboratory variations .*The Courts/Forum at Delhi shall have exclusive
jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).*Test results are not valid for medico legal purposes. * Contact
customer care Tel No. +91-11-39885050 for all queries related to test results.
(#) Sample drawn from outside source.
PatientReportSCSuperPanel.FLOWCYTO_DYNAMIC_SC (Version: 6)
*153672637*
Page 2 of 2